The United Kingdom Prospective Diabetes Study (UKPDS) is the largest ever s
tudy to clarify the role of glycemia and blood pressure control in improvin
g morbidity and mortality in patients with type 2 diabetes. The study exami
ned the impact of glycemia and blood pressure control on microvascular and
macrovascular risk, and if any particular therapy was advantageous for thes
e patients. This articles discusses the background, methodology and results
of the UKPDS and develops recommendations for treatment and management of
patients with type 2 diabetes in the clinical setting.